ModeX Therapeutics clinical trials
Acquired by OPKO Health, Inc., May 9, 2022 · source ↗
The registry lists 4 studies whose lead sponsor is ModeX Therapeutics. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.
Before and after it joined OPKO Health, Inc.
- First submitted before ModeX Therapeutics became part of OPKO Health, Inc.
- 0
- First submitted after ModeX Therapeutics became part of OPKO Health, Inc.
- 4
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- ModeX Therapeutics, An OPKO Health Company4 studies
Something wrong with this grouping? Tell us on the OPKO Health, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All OPKO Health, Inc. studies →
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
Sponsor listed in the registry: ModeX Therapeutics, An OPKO Health Company · First submitted after ModeX Therapeutics became part of OPKO Health, Inc.
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.RecruitingNCT07445971Phase 1
Sponsor listed in the registry: ModeX Therapeutics, An OPKO Health Company · First submitted after ModeX Therapeutics became part of OPKO Health, Inc.
- Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaRecruitingNCT07249905Phase 1/2
Sponsor listed in the registry: ModeX Therapeutics, An OPKO Health Company · First submitted after ModeX Therapeutics became part of OPKO Health, Inc.
- Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced TumorsRecruitingNCT07110584Phase 1/2
Sponsor listed in the registry: ModeX Therapeutics, An OPKO Health Company · First submitted after ModeX Therapeutics became part of OPKO Health, Inc.